|
|
 |
|
Viewing report
|
|
|
|
2011 Trends to Watch: Pharmaceutical Technology
Ovum, Nov 2010, Pages: 29
Introduction
In collaboration with analysts from Datamonitor's Healthcare business unit, in this brief Ovum's Pharmaceutical Technology team outlines the key changes in the pharma industry, explains which trends will have the biggest impact, and analyzes the implications and opportunities of these developments for both pharmaceutical companies and providers of technologies and services.
Features and benefits
- Gives an overview of the current landscape for the global pharmacuetical and biotechnology industries- Offers insight into factors driving the life sciences industry’s need for IT and how vendors can help companies overcome market challenges- Provides strategies to help technology vendors penetrate the life science industry
Highlights
2011 will be a challenging year for the life sciences industry as a result of the dreaded patent cliff, an increase in drug pricing pressures and heightened regulatory scrutiny on drug safety and pharma's marketing tactics.In response to declining sales and rising R&D costs, the industry is expanding out of the developed markets of US, Europe and Japan, into the emerging markets, particularly China and India. Experiencing tremendous growth already, these emerging markets will not be emerging much longer.2011 brings with it many challenges and opportunities for the life sciences industry, and while several uncertainties remain, one thing is certain: technology will be integral to those hoping to see 2012.
Your key questions answered
- Learn about the top trends in the life science industry in 2011- Tailor your go-to-market strategy to address critical issues facing pharmaceutical and biotechnology companies- Identify strategies for expanding business opportunities in the life science industry
|
|
|
|
